Predicting therapeutic outcomes in Myelodysplasia and Acute Myeloid Leukaemia
"A Systems Biology Approach to identifying drug targets and predicting therapeutic outcomes in Myelodysplasia and Acute Myeloid Leukaemia"
John Pimanda is head of the adult cancer program at the Lowy Cancer Research Centre in Sydney. He is a haematologist at the Prince of Wales Hospital (POWH) and an Associate Professor at UNSW Australia. Following the award of his PhD under the supervision of Professor Phil Hogg at UNSW in 2004, he undertook post-doctoral research with Professors Bertie Göttgens and Tony Green at the University of Cambridge as an RG Menzies/CJ Martin research fellow. He returned in 2008 to set up a research program in stem cell biology, cancer and tissue regeneration at UNSW and POWH.
Dr Pimanda will present results from a body of work using functional genomics to develop tools to predict drug response in Myelodysplasia (MDS), identify alternate treatment options for patients who fail current treatment and characterise treatment related changes to the sub-clonal architecture and function of dysplastic haematopoietic stem/progenitor cells (HSPCs). He will also present an integrative analysis of long intergenic non-coding RNA (lincRNAs) expression from 922 acute myeloid leukemia patients. These analyses show that leukemic and normal hematopoietic cell subsets express distinct lincRNAs and that gene signatures composed of as few as three lincRNA genes are independent predictors of clinical outcome across multiple patient cohorts.
If you would like to attend this seminar, please use the "Contact us" link below to express interest and arrange site access.